APO RESEARCH · REPORT
COVID-19 Antibody Detection Kits
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
Product & engineering
Understand the product.
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
Selected research
Market Outlook & Growth Opportunities
Global COVID-19 Antibody Detection Kits Market Outlook and Growth Opportunities 2026
Market perspective
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
In the last several months, global consumption market of COVID-19 Antibody Detection Kits industry developed with the average growth rate of 303% during last two months. In 2020, global consumption of COVID-19 Antibody Detection Kits reached 2838 K Unit on April. At the same time, global consumption of COVID-19 Antibody Detection Kits reached 24.64 M Unit on April.
According to our prediction, Europe is the largest consumer of COVID-19 Antibody Detection Kits in global market.The second place is North America, following Europe.
Read the full market overview
This report provides an overview of the global COVID-19 Antibody Detection Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of COVID-19 Antibody Detection Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents COVID-19 Antibody Detection Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the COVID-19 Antibody Detection Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
COVID-19 Antibody Detection Kits Segment by Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
COVID-19 Antibody Detection Kits Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
COVID-19 Antibody Detection Kits Segment by Application
Hospitals
Scientific Research
COVID-19 Antibody Detection Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global COVID-19 Antibody Detection Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions COVID-19 Antibody Detection Kits market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify COVID-19 Antibody Detection Kits significant trends, drivers, influence factors in global and regions.
6. To analyze COVID-19 Antibody Detection Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COVID-19 Antibody Detection Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of COVID-19 Antibody Detection Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COVID-19 Antibody Detection Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the COVID-19 Antibody Detection Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global COVID-19 Antibody Detection Kits industry.
Chapter 3: Detailed analysis of COVID-19 Antibody Detection Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of COVID-19 Antibody Detection Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of COVID-19 Antibody Detection Kits in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Rapid Diagnostic Test (RDT)
- Enzyme Linked Immunosorbent Assay (ELISA)
- Neutralization Assay
Applications
- Hospitals
- Scientific Research
Companies covered
- Cellex
- Abbott
- Roche
- BioMedomics
- BD
- Henry Schein
- Safecare Bio-Tech
- Mayo Clinic Laboratories
- Chembio Diagnostics
- Mount Sinai Laboratory
- Ortho Clinical Diagnostics
- Zhejiang Orient Gene Biotech
- Innovita Biological Technology
- Guangzhou Wondfo Biotech
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- ADVAITE
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global COVID-19 Antibody Detection Kits Sales Value (2021-2032)
- 1.2.2 Global COVID-19 Antibody Detection Kits Sales Volume (2021-2032)
- 1.2.3 Global COVID-19 Antibody Detection Kits Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 COVID-19 Antibody Detection Kits Market Dynamics
- 2.1 COVID-19 Antibody Detection Kits Industry Trends
- 2.2 COVID-19 Antibody Detection Kits Industry Drivers
- 2.3 COVID-19 Antibody Detection Kits Industry Opportunities and Challenges
- 2.4 COVID-19 Antibody Detection Kits Industry Restraints
3 COVID-19 Antibody Detection Kits Market by Company
- 3.1 Global COVID-19 Antibody Detection Kits Company Revenue Ranking in 2025
- 3.2 Global COVID-19 Antibody Detection Kits Revenue by Company (2021-2026)
- 3.3 Global COVID-19 Antibody Detection Kits Sales Volume by Company (2021-2026)
- 3.4 Global COVID-19 Antibody Detection Kits Average Price by Company (2021-2026)
- 3.5 Global COVID-19 Antibody Detection Kits Company Ranking (2024-2026)
- 3.6 Global COVID-19 Antibody Detection Kits Company Manufacturing Base and Headquarters
- 3.7 Global COVID-19 Antibody Detection Kits Company Product Type and Application
- 3.8 Global COVID-19 Antibody Detection Kits Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global COVID-19 Antibody Detection Kits Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 COVID-19 Antibody Detection Kits Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 COVID-19 Antibody Detection Kits Market by Type
- 4.1 COVID-19 Antibody Detection Kits Type Introduction
- 4.1.1 Rapid Diagnostic Test (RDT)
- 4.1.2 Enzyme Linked Immunosorbent Assay (ELISA)
- 4.1.3 Neutralization Assay
- 4.2 Global COVID-19 Antibody Detection Kits Sales Volume by Type
- 4.2.1 Global COVID-19 Antibody Detection Kits Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global COVID-19 Antibody Detection Kits Sales Volume by Type (2021-2032)
- 4.2.3 Global COVID-19 Antibody Detection Kits Sales Volume Share by Type (2021-2032)
- 4.3 Global COVID-19 Antibody Detection Kits Sales Value by Type
- 4.3.1 Global COVID-19 Antibody Detection Kits Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global COVID-19 Antibody Detection Kits Sales Value by Type (2021-2032)
- 4.3.3 Global COVID-19 Antibody Detection Kits Sales Value Share by Type (2021-2032)
5 COVID-19 Antibody Detection Kits Market by Application
- 5.1 COVID-19 Antibody Detection Kits Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Scientific Research
- 5.2 Global COVID-19 Antibody Detection Kits Sales Volume by Application
- 5.2.1 Global COVID-19 Antibody Detection Kits Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global COVID-19 Antibody Detection Kits Sales Volume by Application (2021-2032)
- 5.2.3 Global COVID-19 Antibody Detection Kits Sales Volume Share by Application (2021-2032)
- 5.3 Global COVID-19 Antibody Detection Kits Sales Value by Application
- 5.3.1 Global COVID-19 Antibody Detection Kits Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global COVID-19 Antibody Detection Kits Sales Value by Application (2021-2032)
- 5.3.3 Global COVID-19 Antibody Detection Kits Sales Value Share by Application (2021-2032)
6 COVID-19 Antibody Detection Kits Regional Sales and Value Analysis
- 6.1 Global COVID-19 Antibody Detection Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global COVID-19 Antibody Detection Kits Sales by Region (2021-2032)
- 6.2.1 Global COVID-19 Antibody Detection Kits Sales by Region: 2021-2026
- 6.2.2 Global COVID-19 Antibody Detection Kits Sales by Region (2027-2032)
- 6.3 Global COVID-19 Antibody Detection Kits Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global COVID-19 Antibody Detection Kits Sales Value by Region (2021-2032)
- 6.4.1 Global COVID-19 Antibody Detection Kits Sales Value by Region: 2021-2026
- 6.4.2 Global COVID-19 Antibody Detection Kits Sales Value by Region (2027-2032)
- 6.5 Global COVID-19 Antibody Detection Kits Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America COVID-19 Antibody Detection Kits Sales Value (2021-2032)
- 6.6.2 North America COVID-19 Antibody Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe COVID-19 Antibody Detection Kits Sales Value (2021-2032)
- 6.7.2 Europe COVID-19 Antibody Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific COVID-19 Antibody Detection Kits Sales Value (2021-2032)
- 6.8.2 Asia-Pacific COVID-19 Antibody Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America COVID-19 Antibody Detection Kits Sales Value (2021-2032)
- 6.9.2 South America COVID-19 Antibody Detection Kits Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa COVID-19 Antibody Detection Kits Sales Value (2021-2032)
- 6.10.2 Middle East & Africa COVID-19 Antibody Detection Kits Sales Value Share by Country, 2025 VS 2032
7 COVID-19 Antibody Detection Kits Country-level Sales and Value Analysis
- 7.1 Global COVID-19 Antibody Detection Kits Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global COVID-19 Antibody Detection Kits Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global COVID-19 Antibody Detection Kits Sales by Country (2021-2032)
- 7.3.1 Global COVID-19 Antibody Detection Kits Sales by Country (2021-2026)
- 7.3.2 Global COVID-19 Antibody Detection Kits Sales by Country (2027-2032)
- 7.4 Global COVID-19 Antibody Detection Kits Sales Value by Country (2021-2032)
- 7.4.1 Global COVID-19 Antibody Detection Kits Sales Value by Country (2021-2026)
- 7.4.2 Global COVID-19 Antibody Detection Kits Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.5.2 USA COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.9.2 France COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.16.2 China COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.19.2 India COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt COVID-19 Antibody Detection Kits Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt COVID-19 Antibody Detection Kits Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt COVID-19 Antibody Detection Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cellex
- 8.1.1 Cellex Company Information
- 8.1.2 Cellex Business Overview
- 8.1.3 Cellex COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Cellex COVID-19 Antibody Detection Kits Product Portfolio
- 8.1.5 Cellex Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Abbott COVID-19 Antibody Detection Kits Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Roche
- 8.3.1 Roche Company Information
- 8.3.2 Roche Business Overview
- 8.3.3 Roche COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Roche COVID-19 Antibody Detection Kits Product Portfolio
- 8.3.5 Roche Recent Developments
- 8.4 BioMedomics
- 8.4.1 BioMedomics Company Information
- 8.4.2 BioMedomics Business Overview
- 8.4.3 BioMedomics COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BioMedomics COVID-19 Antibody Detection Kits Product Portfolio
- 8.4.5 BioMedomics Recent Developments
- 8.5 BD
- 8.5.1 BD Company Information
- 8.5.2 BD Business Overview
- 8.5.3 BD COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.5.4 BD COVID-19 Antibody Detection Kits Product Portfolio
- 8.5.5 BD Recent Developments
- 8.6 Henry Schein
- 8.6.1 Henry Schein Company Information
- 8.6.2 Henry Schein Business Overview
- 8.6.3 Henry Schein COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Henry Schein COVID-19 Antibody Detection Kits Product Portfolio
- 8.6.5 Henry Schein Recent Developments
- 8.7 Safecare Bio-Tech
- 8.7.1 Safecare Bio-Tech Company Information
- 8.7.2 Safecare Bio-Tech Business Overview
- 8.7.3 Safecare Bio-Tech COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Safecare Bio-Tech COVID-19 Antibody Detection Kits Product Portfolio
- 8.7.5 Safecare Bio-Tech Recent Developments
- 8.8 Mayo Clinic Laboratories
- 8.8.1 Mayo Clinic Laboratories Company Information
- 8.8.2 Mayo Clinic Laboratories Business Overview
- 8.8.3 Mayo Clinic Laboratories COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Mayo Clinic Laboratories COVID-19 Antibody Detection Kits Product Portfolio
- 8.8.5 Mayo Clinic Laboratories Recent Developments
- 8.9 Chembio Diagnostics
- 8.9.1 Chembio Diagnostics Company Information
- 8.9.2 Chembio Diagnostics Business Overview
- 8.9.3 Chembio Diagnostics COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Chembio Diagnostics COVID-19 Antibody Detection Kits Product Portfolio
- 8.9.5 Chembio Diagnostics Recent Developments
- 8.10 Mount Sinai Laboratory
- 8.10.1 Mount Sinai Laboratory Company Information
- 8.10.2 Mount Sinai Laboratory Business Overview
- 8.10.3 Mount Sinai Laboratory COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Mount Sinai Laboratory COVID-19 Antibody Detection Kits Product Portfolio
- 8.10.5 Mount Sinai Laboratory Recent Developments
- 8.11 Ortho Clinical Diagnostics
- 8.11.1 Ortho Clinical Diagnostics Company Information
- 8.11.2 Ortho Clinical Diagnostics Business Overview
- 8.11.3 Ortho Clinical Diagnostics COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Ortho Clinical Diagnostics COVID-19 Antibody Detection Kits Product Portfolio
- 8.11.5 Ortho Clinical Diagnostics Recent Developments
- 8.12 Zhejiang Orient Gene Biotech
- 8.12.1 Zhejiang Orient Gene Biotech Company Information
- 8.12.2 Zhejiang Orient Gene Biotech Business Overview
- 8.12.3 Zhejiang Orient Gene Biotech COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Zhejiang Orient Gene Biotech COVID-19 Antibody Detection Kits Product Portfolio
- 8.12.5 Zhejiang Orient Gene Biotech Recent Developments
- 8.13 Innovita Biological Technology
- 8.13.1 Innovita Biological Technology Company Information
- 8.13.2 Innovita Biological Technology Business Overview
- 8.13.3 Innovita Biological Technology COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Innovita Biological Technology COVID-19 Antibody Detection Kits Product Portfolio
- 8.13.5 Innovita Biological Technology Recent Developments
- 8.14 Guangzhou Wondfo Biotech
- 8.14.1 Guangzhou Wondfo Biotech Company Information
- 8.14.2 Guangzhou Wondfo Biotech Business Overview
- 8.14.3 Guangzhou Wondfo Biotech COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Guangzhou Wondfo Biotech COVID-19 Antibody Detection Kits Product Portfolio
- 8.14.5 Guangzhou Wondfo Biotech Recent Developments
- 8.15 Guangdong Hecin-Scientific
- 8.15.1 Guangdong Hecin-Scientific Company Information
- 8.15.2 Guangdong Hecin-Scientific Business Overview
- 8.15.3 Guangdong Hecin-Scientific COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Guangdong Hecin-Scientific COVID-19 Antibody Detection Kits Product Portfolio
- 8.15.5 Guangdong Hecin-Scientific Recent Developments
- 8.16 Dynamiker Biotechnology (Tianjin)
- 8.16.1 Dynamiker Biotechnology (Tianjin) Company Information
- 8.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
- 8.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Antibody Detection Kits Product Portfolio
- 8.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
- 8.17 ADVAITE
- 8.17.1 ADVAITE Company Information
- 8.17.2 ADVAITE Business Overview
- 8.17.3 ADVAITE COVID-19 Antibody Detection Kits Sales, Value and Gross Margin (2021-2026)
- 8.17.4 ADVAITE COVID-19 Antibody Detection Kits Product Portfolio
- 8.17.5 ADVAITE Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 COVID-19 Antibody Detection Kits Value Chain Analysis
- 9.1.1 COVID-19 Antibody Detection Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 COVID-19 Antibody Detection Kits Sales Mode & Process
- 9.2 COVID-19 Antibody Detection Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 COVID-19 Antibody Detection Kits Distributors
- 9.2.3 COVID-19 Antibody Detection Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst